Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease
Clinical trial NCT06112327 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06112327
- Sponsor
- Verve Therapeutics, Inc.
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-09
- Primary completion
- 2039-10-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.